Personal Information
Ulrik Spork
Chairman of the Board
Education & Experience
-
Education :He holds a master's degree in engineering from Danish Technical University and a bachelor's in business administration from Copenhagen Business School.
-
Roles and Expertise :Ulrik Spork is currently active as chairman/board member in a number of emerging life-science and MedTech companies, and as an ad hoc advisor to investment funds and companies. Over 25 years until 2015. Ulrik held senior positions in the Novo Group, including Head of Corporate Development in Novo Nordisk; founder and Senior Partner of Novo Ventures; Managing Partner, Novo Growth Equity and Principal Investments; and member of the executive team in Novo Holdings A/S. Ulrik has served over the last 25+ years as chairman or board member in more than 30 development/early commercialization-stage companies in the life science space, in jurisdictions including France, UK, Sweden, Denmark, Canada, and the USA. His board experience includes Novexel S.A. (Paris, France) and Corus Pharma Inc. (Seattle, USA), both companies engaged in the development of novel anti-infective therapies.